 |
인쇄하기
취소
|
Kolon Pharm to launch new drug for diabetic retinopathy
Kolon Pharm says it will launch Kanakulin (kallidinogenase), a new medicine for treatment of diabetic retinopathy during this month.
Developed by Sanwa Kagaku Kenkyusho Co. in Japan, Kanakulin is a proteolytic enzyme from the serine endopeptidase family found in normal blood and urine. Specifically, Kallikreins are potent vasodilators and hypotensives and increases vascular permeability and ...
Developed by Sanwa Kagaku Kenkyusho Co. in Japan, Kanakulin is a proteolytic enzyme from the serine endopeptidase family found in normal blood and urine. Specifically, Kallikreins are potent vasodilators and hypotensives and increases vascular permeability and ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.